Inventor
Toufike Kanouni
Inventor
La Jolla, CA, US
Overview
Patents· 63 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes25%
C07BGeneral methods of organic chemistry5%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,098,031Inhibitors of RAF kinases202111,084,793Inhibitors of lysine specific demethylase-1202111,028,066Inhibitors of lysine specific demethylase-1202111,020,380Therapeutic compounds202110,927,111Inhibitors of RAF kinases202110,894,788Inhibitors of cyclin-dependent kinases202110,864,202Inhibitors of lysine specific demethylase-1202010,815,234Histone demethylase inhibitors202010,807,956Histone demethylase inhibitors202010,703,739Compositions comprising an inhibitor of lysine specific demethylase-1202010,654,810Inhibitors of lysine specific demethylase-1202010,626,104Inhibitors of lysine specific demethylase-1202010,626,103Inhibitor of lysine specific demethylase-1202010,617,680Therapeutic compounds202010,611,763Histone demethylase inhibitors202010,597,365Histone demethylase inhibitors202010,597,376Inhibitors of lysine specific demethylase-1202010,543,198Inhibitor of lysine specific demethylase-1202010,526,327Histone demethylase inhibitors202010,414,750Inhibitors of lysine specific demethylase-1201910,385,051Inhibitors of lysine specific demethylase-1201910,336,727Histone demethylase inhibitors201910,316,016Compositions comprising an inhibitor of lysine specific demethylase-1201910,273,222Histone demethylase inhibitors201910,207,999Inhibitors of lysine specific demethylase-1201910,208,039Histone demethylase inhibitors201910,202,381Histone demethylase inhibitors201910,202,360Therapeutic compounds201910,179,769Histone demethylase inhibitors201910,131,664Inhibitors of lysine specific demethylase-1201810,112,940Histone demethylase inhibitors201810,100,046Inhibitors of lysine specific demethylase-1201810,047,069Compositions comprising an inhibitor of lysine specific demethylase-1201810,040,779Histone demethylase inhibitors201810,030,017Histone demethylase inhibitors201810,023,543Inhibitors of lysine specific demethylase-1201810,011,583Inhibitors of lysine specific demethylase-120189,994,562Histone demethylase inhibitors20189,963,441Histone demethylase inhibitors20189,944,636Inhibitors of lysine specific demethylase-120189,902,719'Inhibitors of lysine specific demethylase-1'20189,828,343Histone demethylase inhibitors20179,828,358Compositions comprising an inhibitor of lysine specific demethylase-120179,822,119'Inhibitors of lysine specific demethylase-1'20179,776,974'Inhibitors of lysine specific demethylase-1'20179,771,329'Inhibitors of lysine specific demethylase-1'20179,725,441'Histone demethylase inhibitors'20179,701,657'Histone demethylase inhibitors'20179,643,965'Histone demethylase inhibitors'20179,617,242'Histone demethylase inhibitors'20179,611,221'Histone demethylase inhibitors'20179,573,930'Inhibitors of lysine specific demethylase-1'20179,527,829'Histone demethylase inhibitors'20169,447,045'Histone demethylase inhibitors'20169,365,566'Cinnoline derivatives'20169,255,097'Inhibitors of lysine specific demethylase-1'20169,133,166'Histone demethylase inhibitors'20159,085,534'Histone demethylase inhibitors'20158,969,343'Histone demethylase inhibitors'20158,952,151'Histone demethylase inhibitors'20158,785,429'Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK'20148,420,816'Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK'20138,022,057'MAPK/ERK kinase inhibitors'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2016Patents assigned to TAKEDA PHARMACEUTICAL (4)· patent assignee history
2011–2021Based in San Diego, CA, US· patent location history
2015–2018Patents assigned to QUANTICEL PHARMACEUTICALS INC (11)· patent assignee history
2015–2020Based in La Jolla, CA, US· patent location history
2016–2021Patents assigned to CELGENE QUANTICEL RES INC (50)· patent assignee history
2017–2021Based in Rancho Santa Fe, CA, US· patent location history
2017Based in Rancho Cucamonga, CA, US· patent location history
2020Patents assigned to CALGENE QUANTICEL RES INC (1)· patent assignee history
2021Patents assigned to KINNATE BIOPHARMA INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE QUANTICEL RES INC | 50 | 2016–2021 |
| QUANTICEL PHARMACEUTICALS INC | 11 | 2015–2018 |
| TAKEDA PHARMACEUTICAL | 4 | 2011–2016 |
| KINNATE BIOPHARMA INC | 3 | 2021 |
| CALGENE QUANTICEL RES INC | 1 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| La Jolla, California, US | 33 | 2015–2020 |
| Rancho Santa Fe, California, US | 23 | 2017–2021 |
| San Diego, California, US | 6 | 2011–2021 |
| Rancho Cucamonga, California, US | 1 | 2017 |